LYKALABS — Lyka Labs Share News
0.000.00%
Last trade - 00:00- IN₹2.99bn
- IN₹3.40bn
- IN₹1.28bn
Brief: Lyka Labs Gets Indian Patent For Pregabalin Gel 8% Valid Through 2043
India's Lyka Labs secures drug patent for diabetes-related conditions; shares surge
India's Lyka Labs climbs after regulatory body approves Pregabalin Gel
Brief: Lyka Labs Gets Permission From CDSCO To Manufacture, Market Pregabalin Gel 8% W/W In India
Brief: Lyka Labs Approves Filing Of Fresh Application Of Scheme Of Amalgamation Of Lyka Exports With Co
Brief: Lyka Labs Says NCLT Rejects Petition For Amalgamation Of Unit Lyka Exports With Co
Brief: Lyka Labs Re-Appointed Kunal Gandhi As Managing Director
India's Lyka Labs up 6% on regulatory nod for product launch
Brief: India's Lyka Labs March-Quarter Consol Net Loss After Tax Narrows
India's Lyka Labs rises as it considers share allotment to IPCA Labs
Brief: Lyka Labs Considered Issue Of Shares Upon Conversion Of Warrants To IPCA Laboratories
Brief: Lyka Labs Issued 2 million shares to IPCA Laboratories
Brief: Lyka Labs To Consider Fund Raise
India's Lyka Labs rises on Agilis animal healthcare business deal
Brief: Lyka Labs Finalised And Signed Agreement With Agilis Healthcare
Brief: SEBI Appellate Tribunal Cut Debarment Period Of Lyka Labs From Co Accessing Capital Market
India's Lyka Labs surges as regulator allows access to capital market
Brief: Lyka Labs Approves Sale Of Land At Dharampur, Valsad And Premises At Shivshakti Industrial Estate, Mumbai
Brief: Lyka Labs Says Made Full Payment Of Outstanding Amount Of RSF 1 Facility, TL 2 Facility